Overview by Region

FY ended March 2025

• Japan: Sales increased 2.0%. The Company concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. The Company also focused on its consumables and services business as well as strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. As a result of these initiatives, domestic sales increased. Sales of AEDs increased favorably in the PAD (public access defibrillation) market. Sales in the university and clinic markets increased, while sales in the public hospital market remained flat. Sales in the private hospital market decreased compared to the strong growth due to large orders in FY2023. Sales of Treatment Equipment achieved double-digit growth and sales of Physiological Measuring Equipment also increased. Sales of Patient Monitors and Other Medical Equipment decreased. 
• International: Sales increased 0.7% on a yen basis due to currency effect. Sales on a local currency basis decreased due to lower sales in Asia & Other and Latin America, as well as the impact of a change in the fiscal term of Defibtech, LLC according to the reorganization of subsidiaries in the U.S. in FY2023. Sales of Other Medical Equipment increased favorably and sales of Patient Monitors also increased. Sales of Treatment Equipment and Physiological Measuring Equipment decreased.
  *In the previous fiscal year, Defibtech, LLC changed its fiscal term from end on December 31 to end on March 31, according to the reorganization of U.S. subsidiaries. In FY2023 ended March 31, 2024, Nihon Kohden consolidated the 15 months of Defibtech’s operating results from January 1, 2023 to March 31, 2024.

FY ended March 2025

• North America: Sales increased 13.1%. Sales of patient monitors, ventilators, and neurology products achieved double-digit growth, while sales of AEDs decreased.
• Latin America: Sales decreased 10.8%. Sales decreased mainly in Costa Rica and Columbia compared to the strong performance in FY2023, while sales in Brazil increased favorably.
• Europe: Sales decreased 4.2%. Sales decreased, mainly in the U.K. and the Netherlands, although sales in Germany and Italy increased.
• Asia & Other: Sales decreased 13.1%. Sales decreased, mainly in China. Sales in the Middle East & Africa also decreased compared to the strong growth due to large orders in Morocco in FY2023.
   

Overseas Sales by Geographic Segments

Years ended March 31